Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
LetterLetter

The Diagnostic, Prognostic, and Differential Value of Enhanced MR Imaging in Guillain-Barré Syndrome

H.-f. Li and X.-j. Ji
American Journal of Neuroradiology August 2011, 32 (7) E140; DOI: https://doi.org/10.3174/ajnr.A2620
H.-f. Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
X.-j. Ji
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

Although we appreciate the excellent images of enhanced cranial nerves in pediatric patients with Guillain-Barré syndrome (GBS) and their contribution to the understanding of GBS as a continuum rather than distinct entities, we do not agree with Zuccoli et al1 that brain MR imaging should be considered in the routine evaluation in pediatric patients with GBS.

First, we would like to know why the authors performed enhanced MR imaging in the clinically diagnosed and laboratory-supported patients with GBS. GBS is a well-known inflammatory disease of peripheral nerves, including the spinal nerves and cranial nerves. Albuminocytologic dissociation is the hallmark of GBS. Moreover, electrophysiologic examinations may reveal demyelinating and/or axonal involvement. In the initial phase of GBS, breakdown of the blood-nerve barrier is the characteristic pathologic change, which may lead to enhancement of nerve roots. The study confirmed this. The diagnosis of GBS is based on clinical evaluation and electrophysiologic and CSF profiles.

Is there additional diagnostic value for GBS with an enhanced scan? In their series, 70.6% of the patients were found to have elevated CSF protein levels and 85.7% had positive electrophysiologic findings for GBS, which supported definite GBS.1 The authors did not provide MR imaging data of patients with negative CSF or electrophysiology findings. Asymptomatic enhancement of nerve roots was found in this study, and the enhancement had no clinical association.1 If no other features support the diagnosis of GBS, perhaps the asymptomatic enhancement may give a clue to the inflammatory process of GBS. Moreover, the authors did not provide the relationship between enhancement and the clinical and electrophysiologic features. Therefore, we cannot know if enhancement may help to determine the subtypes of GBS (acute inflammatory demyelinating polyneuropathy, acute motor axonal neuropathy, or acute motor-sensory axonal neuropathy).

Second, we wonder whether the enhancement may have prognostic value. As the authors noted, though prominent nerve root enhancement accompanied an increased severity of leg weakness, the correlation between intracranial findings and clinical outcomes was poorly established. However, they did not provide the details of the outcome of the patients with enhanced nerve roots. The prognostic value will be determined by adjusting confounding factors, such as baseline severity, electrophysiologic classification (demyelinating or axonal), baseline CSF protein levels, immune-modulating therapies, and the time between scanning and the initial symptoms.

Third, is the enhancement significant in differentiating GBS from chronic inflammatory demyelinating neuropathy (CIDP) presenting as GBS? A small portion of patients with CIDP may present with relatively rapid progression to the nadir within 4 weeks after the onset, but they will relapse or progress in the long run.2 Researchers have found several clues to differentiate it from GBS.3 Because enhancement and thickening of nerve roots is also seen in CIDP,4 the enhanced scan may help the differentiation. The grade of enhancement (absent, present, or strongly present) used in the Zuccoli study along with the morphology (thickening or not) may give a clue. Again, the time of scanning is important. We hypothesize that if there is a difference between GBS and CIDP presenting as GBS, the differential value will be maximal when scanning is performed in the “recovery” phase (eg, 6–8 weeks after the onset), when acute inflammation subsides in GBS while chronic inflammation persists in CIDP.

In conclusion, enhanced MR imaging need not be considered in the routine evaluation in GBS until its diagnostic, prognostic, and differential value is confirmed by prospective studies.

References

  1. 1.↵
    1. Zuccoli G,
    2. Panigrahy A,
    3. Bailey A,
    4. et al
    . Redefining the Guillain-Barré spectrum in children: neuroimaging findings of cranial nerve involvement. AJNR Am J Neuroradiol 2011;32:639–42
    Abstract/FREE Full Text
  2. 2.↵
    1. Odaka M,
    2. Yuki N,
    3. Hirata K
    . Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome. J Neurol 2003;250:913–16
    CrossRefPubMed
  3. 3.↵
    1. Dionne A,
    2. Nicolle MW,
    3. Hahn AF
    . Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve 2010;41:202–07
    PubMed
  4. 4.↵
    1. Duggins AJ,
    2. McLeod JG,
    3. Pollard JD,
    4. et al
    . Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 1999;122:1383–90
    Abstract/FREE Full Text
  • Copyright © American Society of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 32 (7)
American Journal of Neuroradiology
Vol. 32, Issue 7
1 Aug 2011
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Diagnostic, Prognostic, and Differential Value of Enhanced MR Imaging in Guillain-Barré Syndrome
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Diagnostic, Prognostic, and Differential Value of Enhanced MR Imaging in Guillain-Barré Syndrome
H.-f. Li, X.-j. Ji
American Journal of Neuroradiology Aug 2011, 32 (7) E140; DOI: 10.3174/ajnr.A2620

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Diagnostic, Prognostic, and Differential Value of Enhanced MR Imaging in Guillain-Barré Syndrome
H.-f. Li, X.-j. Ji
American Journal of Neuroradiology Aug 2011, 32 (7) E140; DOI: 10.3174/ajnr.A2620
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • Reply:
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Fair Performance of CT in Diagnosing Unilateral Vocal Fold Paralysis
  • Reply:
  • Regarding “Altered Blood Flow in the Ophthalmic and Internal Carotid Arteries in Patients with Age-Related Macular Degeneration Measured Using Noncontrast MR Angiography at 7T”
Show more LETTERS

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2022 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2023 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire